We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
+9.55%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$222B
AUM Growth
+$15.6B
Cap. Flow
-$802M
Cap. Flow %
-0.36%
Top 10 Hldgs %
20.89%
Holding
3,394
New
124
Increased
1,572
Reduced
1,272
Closed
134

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$489M
2
PYPL icon
PayPal
PYPL
+$464M
3
DG icon
Dollar General
DG
+$438M
4
SNPS icon
Synopsys
SNPS
+$432M
5
MSCI icon
MSCI
MSCI
+$414M

Sector Composition

Rank Sector Weight
1 Technology 23.94%
2 Healthcare 18.36%
3 Financials 13.63%
4 Consumer Discretionary 10.13%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRC icon
2751
Gorman-Rupp
GRC
$2.13B
$395K ﹤0.01%
15,437
+900
+6% +$23.8K
ICPT
2752
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$395K ﹤0.01%
31,970
+7,600
+31% +$108K
NKTX icon
2753
Nkarta
NKTX
$162M
$395K ﹤0.01%
66,000
+4,100
+7% +$41.4K
IJK icon
2754
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.9B
$394K ﹤0.01%
5,775
+469
+9% +$32.2K
FUBO icon
2755
FuboTV Inc
FUBO
$256M
$394K ﹤0.01%
18,865
+7,309
+63% +$268K
ATRA icon
2756
Atara Biotherapeutics
ATRA
$69.5M
$392K ﹤0.01%
4,786
+504
+12% +$52.5K
BOC icon
2757
Boston Omaha
BOC
$434M
$392K ﹤0.01%
14,800
+700
+5% +$18.4K
UBA
2758
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$392K ﹤0.01%
20,685
+1,930
+10% +$35.3K
JAMF
2759
DELISTED
Jamf
JAMF
$391K ﹤0.01%
18,367
-61
-0.3% -$1.34K
SOVO
2760
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$391K ﹤0.01%
27,200
+7,400
+37% +$104K
ELIQ
2761
DELISTED
Electriq Power Holdings, Inc.
ELIQ
$390K ﹤0.01%
38,336
-111,664
-74% -$1.12M
PICC
2762
DELISTED
Pivotal Investment Corporation III
PICC
$389K ﹤0.01%
38,445
-109,130
-74% -$1.09M
EOLS icon
2763
Evolus
EOLS
$407M
$389K ﹤0.01%
51,800
+3,800
+8% +$29.4K
LGF.A
2764
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$387K ﹤0.01%
67,800
+8,700
+15% +$61.5K
NAAC
2765
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
$387K ﹤0.01%
38,287
-14,483
-27% -$145K
ARCT icon
2766
Arcturus Therapeutics
ARCT
$164M
$387K ﹤0.01%
22,800
HIFS icon
2767
Hingham Institution for Saving
HIFS
$613M
$386K ﹤0.01%
1,400
+200
+17% +$52.7K
OCGN icon
2768
Ocugen
OCGN
$427M
$386K ﹤0.01%
296,900
+103,700
+54% +$162K
CRBG icon
2769
Corebridge Financial
CRBG
$14.3B
$386K ﹤0.01%
+19,228
New +$406K
PAHC icon
2770
Phibro Animal Health
PAHC
$1.43B
$386K ﹤0.01%
28,751
+3,518
+14% +$47.2K
PTVE
2771
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$383K ﹤0.01%
33,736
+4,900
+17% +$53.5K
IIIV icon
2772
i3 Verticals
IIIV
$404M
$382K ﹤0.01%
15,700
+3,100
+25% +$69.9K
FDMT icon
2773
4D Molecular Therapeutics
FDMT
$543M
$380K ﹤0.01%
+17,100
New +$264K
RXT icon
2774
Rackspace Technology
RXT
$980M
$380K ﹤0.01%
128,698
+44,412
+53% +$188K
ORGO icon
2775
Organogenesis Holdings
ORGO
$328M
$379K ﹤0.01%
140,933
+18,064
+15% +$52.7K

Similar funds

AllianceBernstein's Q4 2022 Portfolio in Review

As of Q4 2022, AllianceBernstein held 3,394 positions worth $222B, up 7.6% from $207B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

AllianceBernstein's Q4 2022 filing shows 124 new, 1,572 increased, 1,272 reduced and 134 closed positions. Its largest new stake was Unilever: 2,996,697 shares worth $170M. The largest sale was Alphabet (Google) Class C, an estimated $887M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • AllianceBernstein's largest Q4 2022 buy was Unilever: 2,996,697 shares worth $170M.
  • AllianceBernstein added most to Illumina in Q4 2022, an estimated $489M increase.
  • AllianceBernstein's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $887M.
  • AllianceBernstein fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $343M.
  • AllianceBernstein's ten largest holdings make up 21% of its $222B portfolio in Q4 2022.
  • AllianceBernstein opened 124 new positions and closed 134 in Q4 2022.
  • AllianceBernstein's portfolio value rose 7.6% quarter-over-quarter to $222B.

Based on AllianceBernstein's 13F filing for Q4 2022, filed 15 Feb 2023.